BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//NextConsensus//Registered forecast deadlines//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FF-063 deadline
X-WR-CALDESC:Event deadlines of registered forecasts. Dates\, names\, and l
 inks only.
REFRESH-INTERVAL;VALUE=DURATION:P1D
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:ff-063@nextconsensus.com
DTSTAMP:20261107T000000Z
DTSTART;VALUE=DATE:20270303
DTEND;VALUE=DATE:20270304
SUMMARY:FF-063 deadline: Zanzalintinib · metastatic colorectal cancer appr
 oval
DESCRIPTION:Registered forecast FF-063 (FDA)\, Zanzalintinib · metastatic 
 colorectal cancer approval. It asks whether this happens by 2027-03-03. Th
 e record: https://nextconsensus.com/forecast/ff-063/
URL:https://nextconsensus.com/forecast/ff-063/
CATEGORIES:Registered forecast,FDA
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR